| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00016 | 1 |